Rockefeller Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.2M Sell
170,754
-767
-0.4% -$63.6K 0.03% 497
2025
Q1
$13.9M Sell
171,521
-21,124
-11% -$1.71M 0.03% 466
2024
Q4
$17.3M Buy
192,645
+14,142
+8% +$1.27M 0.04% 382
2024
Q3
$17.6M Buy
178,503
+52,525
+42% +$5.19M 0.05% 380
2024
Q2
$11.7M Buy
125,978
+11,524
+10% +$1.07M 0.03% 463
2024
Q1
$10.9M Buy
114,454
+12,950
+13% +$1.23M 0.03% 476
2023
Q4
$9.06M Buy
101,504
+865
+0.9% +$77.2K 0.03% 484
2023
Q3
$7.35M Sell
100,639
-5,442
-5% -$397K 0.03% 497
2023
Q2
$8.83M Buy
106,081
+173
+0.2% +$14.4K 0.03% 469
2023
Q1
$8.07M Sell
105,908
-165,110
-61% -$12.6M 0.03% 469
2022
Q4
$22.5M Buy
271,018
+175,429
+184% +$14.6M 0.11% 204
2022
Q3
$7.58M Buy
95,589
+11,525
+14% +$914K 0.04% 434
2022
Q2
$6.24M Buy
84,064
+5,482
+7% +$407K 0.03% 456
2022
Q1
$7.06M Buy
78,582
+30,323
+63% +$2.73M 0.03% 458
2021
Q4
$5.4M Buy
48,259
+13,918
+41% +$1.56M 0.03% 517
2021
Q3
$4.32M Buy
34,341
+16,224
+90% +$2.04M 0.02% 511
2021
Q2
$2.45M Buy
18,117
+8,022
+79% +$1.09M 0.01% 661
2021
Q1
$1.37M Sell
10,095
-49,372
-83% -$6.69M 0.01% 692
2020
Q4
$8.37M Buy
59,467
+56,148
+1,692% +$7.9M 0.06% 247
2020
Q3
$369K Buy
3,319
+715
+27% +$79.5K ﹤0.01% 873
2020
Q2
$292K Buy
2,604
+1,100
+73% +$123K ﹤0.01% 855
2020
Q1
$116K Buy
1,504
+204
+16% +$15.7K ﹤0.01% 978
2019
Q4
$124K Buy
1,300
+800
+160% +$76.3K ﹤0.01% 905
2019
Q3
$38K Sell
500
-2,992
-86% -$227K ﹤0.01% 1055
2019
Q2
$306K Buy
+3,492
New +$306K ﹤0.01% 517
2019
Q1
Sell
-24,705
Closed -$1.77M 1942
2018
Q4
$1.77M Buy
+24,705
New +$1.77M 0.03% 196
2018
Q3
Sell
-1,365
Closed -$130K 790
2018
Q2
$130K Buy
+1,365
New +$130K ﹤0.01% 367